MORGAN STANLEY PLC/CALL/CENCORA/240/0.1/21.03.25

MORGAN STANLEY PLC/CALL/CENCORA/240/0.1/21.03.25 Stock

DE000MG106J5

Real-time Bid/Ask 07:16:35 2024-05-29 am EDT
0.75 ^EUR / 1 ^EUR	+5.42%

Current month	-65.13%
1 month	-67.83%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart CENCORA, INC.

Chart MORGAN STANLEY PLC/CALL/CENCORA/240/0.1/21.03.25

Latest news about CENCORA, INC.

Baird Adjusts Price Target on Cencora to $280 From $277	06:01am	MT
Cencora Notifies Individuals Affected by Data Breach	May. 24	MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	May. 23
The market is good to go until Nvidia’s next quarterly results	May. 23

More news

Quotes 5-day view

Date	Price	Change
24-05-29	0.74	-10.84%
24-05-28	0.83	0.00%
24-05-27	0.83	-2.35%
24-05-24	0.85	-7.61%
24-05-23	0.92	+9.52%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 05:50 am EDT

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	CENCORA, INC.
Issuer	Morgan Stanley
WKN	MG106J
ISIN	DE000MG106J5
Date issued	2024-03-28
Strike	240 $
Maturity	2025-03-21 (297 Days)
Parity	10 : 1
Emission price	2.8 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	3.1 €
Lowest since issue	0.74 €
Delta	0.38x
Omega	9.219
Premium	15.11x
Gearing	24.32x
Moneyness	0.9009
Difference Strike	23.79 $
Difference Strike %	+9.91%
Spread	0.16 €
Spread %	17.78%
Theoretical value	0.8250
Implied Volatility	19.03 %
Total Loss Probability	68.10 %
Intrinsic value	0.000000
Present value	0.8250
Break even	248.95 €
Theta	-0.02x
Vega	0.07x
Rho	0.05x

Company Profile

Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).

Sector

More about the company

Ratings for Cencora, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Cencora, Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

216.2 USD

Average target price

255.1 USD

Spread / Average Target

+18.00%

Consensus